Induction of tumor regression by intratumoral STING agonists combined with anti–programmed death‐L1 blocking antibody in a preclinical squamous cell carcinoma model
Shekhar K. Gadkaree; Juan Fu; Rupashree Sen; Michael J. Korrer; Clint Allen; Young J. Kim
Author Information: Department of Otolaryngology
|Checking for direct PDF access through Ovid|
Abstract unavailable for this article.